Pharmafile Logo
Pharmafocus logo
Advanced Search

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

Appointment

Canada latest country to suspend sales of Novartis vaccines

October 30, 2012
Manufacturing and Production Canada, Novartis, vaccines

Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …

News

Shionogi and ViiV strike new HIV deal

October 30, 2012
Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

News

Pharmalink AB strengthens senior management

October 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB

Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …

Appointment
Boehringer image

Boehringer to increase production of Respimat inhaler

October 30, 2012
Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist

Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …

News
Patheon image

Patheon buys softgel specialist Banner in $255m deal

October 30, 2012
Manufacturing and Production Capsugel, Patheon, banner pharmacaps

Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …

News
teva image

Teva’s CML drug approved

October 29, 2012
Research and Development, Sales and Marketing FDA, Synribo, Teva

Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …

News

Almirall welcomes UCB head into Board of directors

October 29, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr

Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

Appointment
Novartis image

EU countries suspend sales of Novartis flu vaccines

October 29, 2012
Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines

Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …

News
Portsmouth

The NHS revolution – one wave at a time

October 26, 2012
Sales and Marketing CCGs, NHS, pharma-NHS partnerships

 The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …

Feature

Turning business intelligence managers into business performance leaders

October 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, MSI, business leaders, intelligence

Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …

Feature
Astrazeneca image

Sharp fall for AstraZeneca

October 26, 2012
Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

News
pat_mccauley_214x164

Astellas announces compliance officer for the Americas

October 26, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley

Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …

Appointment
Shire image

Shire poaches new head from Bayer

October 26, 2012
Sales and Marketing Angus Russell, Flemming Omskov, Shire

Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …

News
FDA image

Contaminated steroids blamed for deadly meningitis outbreak

October 25, 2012
Manufacturing and Production FDA, GMP, NECC

As many as 14,000 patients may have been exposed to contaminated steriods that have led to 23 deaths due to …

News
lilly corporate hq image

Lilly censured for rep photo

October 25, 2012
Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly

Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …

News
Astrazeneca image

AstraZeneca and Ironwood announce $150 million China pact

October 25, 2012
Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …

News
Doctor and computer image

Perception of pharma online ‘negative’

October 25, 2012
Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health

Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …

News

Management Forum NSF-DBA Medical Devices Certification Programme

October 24, 2012
Research and Development

Management Forum has teamed up with NSF-DBA, experts in medical device professional training, to bring certification programmes aimed at demonstrating …

News
Press release
Novo Nordisk image

European green light for Novo’s Tresiba

October 24, 2012
Sales and Marketing EMA, Novo Nordisk, Tresiba

The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026